FCP Biotech Holding
2
14M
1
0.50
1
- Stages of investment
- Areas of investment
Summary
The company was established in Europe in Germany. The main office of represented VC is situated in the Gru00e4felfing.
Among the most popular portfolio startups of the fund, we may highlight SuppreMol. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany.
The typical case for the fund is to invest in rounds with 5 participants. Despite the FCP Biotech Holding, startups are often financed by MIG AG, KfW, Bayern Kapital GmbH. The meaningful sponsors for the fund in investment in the same round are Santo Holding, MIG AG, BioMedPartners. In the next rounds fund is usually obtained by MIG AG, Santo Holding, BioMedPartners.
The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2010. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.50
- Investments by industry
- Health Care (2)
- Medical Device (2)
- Biotechnology (2)
- Investments by region
-
- Germany (2)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 236M
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
- Avg. multiplicator
- 3.88
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| SuppreMol | 17 Dec 2010 | Biotechnology, Health Care, Medical Device | Late Stage Venture | 18M | Germany, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.